Description
Pen Content: Andarine S4 – 80mg, GW501516 – 80mg, SR9009 – 80mg
What is the Recomposition Stack?
Recomposition Stack is an innovative formula developed for scientific research focused on body recomposition—the simultaneous development of lean muscle mass and reduction of body fat. The combination includes three synergistic compounds: Andarine S4, GW501516 (Cardarine), and SR9009 (Stenabolic), each with well-studied metabolic and functional mechanisms.
The pen contains a total of 240mg of active ingredients in 3ml, with a pre-mixed and stabilized formula for subcutaneous use in scientific settings. This ensures high bioavailability and precise dosing.
Key Components and Mechanism of Action:
Andarine (S4) is a selective androgen receptor modulator (SARM) that shows strong receptor activity in muscle and bone tissue. It is used in research protocols aimed at improving muscle density and strength, particularly under caloric deficit conditions.
GW501516 (Cardarine) is a PPAR-δ agonist that modulates fatty acid metabolism, enhances mitochondrial efficiency, and supports fat oxidation as a primary energy source. It is suitable for studies focused on endurance, glucose control, and lipid balance, without interacting with the androgen system.
SR9009 (Stenabolic) is a REV-ERBα agonist that regulates circadian rhythms and cellular energy homeostasis. It is known for its ability to increase mitochondrial density, stimulate resting energy expenditure, and optimize cellular metabolism. It is often used in synergy with Cardarine in research protocols aiming to improve metabolic efficiency.
Synergistic Effect of the Recomposition Stack:
The combination of Andarine S4, GW501516, and SR9009 creates a potent yet balanced effect suitable for research protocols involving fat loss, muscle preservation, and enhancement of physical performance.
Andarine contributes to anabolic stability, while Cardarine and SR9009 work synergistically to improve mitochondrial function, energy utilization, and endurance.
This type of composition is particularly suitable for protocols involving caloric restriction, intense physical activity, or periods of metabolic adaptation where the goal is to simultaneously achieve muscle definition, functional strength, and a better metabolic profile.
Scientifically Supported Potential Benefits:
Recomposition Stack is formulated to address both anabolic stability and metabolic optimization in short- to mid-term research cycles.
- Supports muscle tissue preservation during caloric deficits
- Stimulates fatty acid oxidation and improves lipid balance
- Enhances mitochondrial efficiency and energy production
- Aids in increasing endurance and workload capacity
- Maintains muscle definition and dryness without water retention
- Suitable for research protocols focused on body recomposition and metabolic regulation
Dosage and Use in Research Protocols:
Recommended research protocol: 10 units once daily, for a duration of 4–8 weeks, followed by a rest period of 3–5 weeks.
Total pen content: 300 units
Maintaining optimal dosage and monitoring application duration play a crucial role in limiting the manifestation of side effects.
Possible Side Effects:
Currently, there is insufficient published clinical data regarding long-term usage profiles. In laboratory settings, tolerability is generally good, but as with any compound administered subcutaneously, individual reactions cannot be excluded.
Potential local effects related to the application method may include redness, sensitivity, discomfort, or mild swelling at the injection site. In longer cycles and higher doses, some models have explored possible effects on endogenous hormonal regulation, which may vary depending on dosage, duration, and individual sensitivity.
Strict monitoring of both dosage and duration is recommended for all research protocols.
For laboratory purposes and personal observation only.
